Efficacy, tolerability and practicality of use of inhaled methoxyflurane in patients with moderate-to-severe trauma-related pain rescued from hostile mountainous environments by the Helicopter Emergency Medical Service (HEMS) in Italy: METEORA Protocol
Phase of Trial: Phase III
Latest Information Update: 27 Mar 2019
Price : $35 *
At a glance
- Drugs Methoxyflurane (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms METEORA
- Sponsors Mundipharma Research
- 27 Mar 2019 According to a Mundipharma GmbH media release, first patient has been enrolled into the trial. Professor Franco Marinangeli is the lead investigator and Giovanni Sbrana (Grosseto Helicopter Emergency Medical Service) is a Principal Investigator.
- 27 Mar 2019 Status changed from not yet recruiting to recruiting, according to a Mundipharma GmbH media release.
- 18 Nov 2018 New trial record